Added to YB: 2026-08-25
Pitch date: 2026-08-21
CAI [bullish]
Caris Life Sciences, Inc.
+1.12%
current return
Author Info
Krypton Research provides long/short thematic investing research. Sign up for the newsletter.
Company Info
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
Market Cap
$7.4B
Pitch Price
$25.84
Price Target
40.00 (+52%)
Dividend
N/A
EV/EBITDA
38.34
P/E
70.81
EV/Sales
7.16
Sector
Biotechnology
Category
growth
Blood Money - Caris Life Sciences, Inc.
CAI: Profitable AI oncology data platform (mkt cap $5.2B, EV $4.8B, 4.8x sales). 2025 rev $812M (+97%), Q1'26 $216M (+79%), gross margin 47%→65%, +$138M adj EBITDA, FCF+, $826M cash vs $400M debt. MI Profile cash engine feeds Assure/Detect screening option. Base $28, bull $40 (+116%), bear $13.50 (-27%) on 2027 sales. Risks: growth deceleration to mid-20s, reimbursement resets, Roche competition.
Read full article (9 min)